Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep896 | Thyroid cancer | ECE2015

Lymphocytic thyroiditis and differentiated thyroid cancer – challenges in follow-up

Oliveira Diana , Ribeiro Cristina , Martins Maria Joao , Paiva Sandra , Melo Miguel , Moreno Carolina , Guelho Daniela , Vicente Nuno , Cardoso Luis , Martins Diana , Carrilho Francisco

Introduction: Chronic lymphocytic thyroiditis (LT) is a very common condition, and its coexistence with papillary thyroid carcinoma has often been reported. Analytical and echographic challenges must be kept in mind in the follow-up of patients with both these disorders.Case report:: We present the case of a woman with a history of multinodular goitre who underwent left thyroidectomy and isthmectomy at the age of 43, with the histopathological finding of...

ea0035p1111 | Thyroid Cancer | ECE2014

Prognostic implications of stage pT3 in well differentiated thyroid cancer

Moreno Carolina , Melo Miguel , Pires Luis , Cardoso Luis , Ribeiro Cristina , Ruas Luisa , Saraiva Joana , Guelho Daniela , Vicente Nuno , Costa Gracinda , Carrilho Francisco

Introduction: The TNM staging system for well differentiated thyroid cancer (WDTC) considers tumours over 4 cm diameter limited to the thyroid or tumours with minimal extra-thyroid extension to be classified as pT3. This stage can be considered quite heterogeneous, as different clinical and pathologic characteristics seem to have distinct prognosis value.Aims: To determine prognostic factors amongst clinical, laboratorial, histologic and radiologic chara...

ea0070aep117 | Adrenal and Cardiovascular Endocrinology | ECE2020

Diagnosis, treatment and survival of adrenocortical carcinoma: 28 years of experience

Catarino Diana , Silva Diana , Guiomar Joana , Moreno Carolina , Ribeiro Critina , Gomes Leonor , Fadiga Lucia , Lavrador Mariana , Vieira Inês , Caetano Rui , Figueiredo Arnaldo , Paiva Isabel

Introduction: Adrenocortical carcinoma is a rare endocrine disease characterized by an aggressive behaviour with a poor prognosis. Clinical experience, even with a little number of patients, has enhanced knowledge about this malignancy, in most cases challenging.Objective: Characterization of patients with adrenocortical carcinoma followed at the endocrine department of a hospital centre, between 1991 and 2019.Methods: Retrospectiv...

ea0029p412 | Clinical case reports - Thyroid/Others | ICEECE2012

Pseudo malabsorption of levothyroxine

Alves M. , Rodrigues D. , Baptista C. , Ribeiro C. , Oliveira P. , Vieira A. , Gouveia S. , Saraiva J. , Moreno C. , Bastos M. , Carvalheiro M.

Background: Therapy with levothyroxine (L-T4) is essential in hypothyroidism treatment. The marked elevation of thyrotropin (TSH) in patients treated with appropriate doses of L-T4 is rare and can result from malabsorption, drug interaction or poor adherence. The non-adherence, omitted by the patient, is called pseudo malabsorption.Clinical report: ACCS, female, 30 years old, hospitalized for persistent...

ea0022p552 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Incidentally found nonfunctioning pituitary macroadenomas: should we suspect them earlier?

Gomes Leonor , Paiva Isabel , Ribeiro Cristina , Santos Jacinta , Vieira Alexandra , Martinho Mariana , Alves Marcia , Gouveia Sofia , Rito Manuel , Belo Francisco , Rebelo Olinda , Carvalheiro Manuela

Background: Nonfunctioning pituitary adenomas are commonly diagnosed as large tumors. Most are detected incidentally during imaging studies. The aim of this study was to evaluate clinical presentation, characteristics and outcome of nonfunctioning pituitary macroadenomas incidentally (NFPMI) discovered.Methods: Twenty-seven patients (mean age 58.9 years, 45–82; 18 males:9 females) with NFPMI were studied. They represent 13.1% of NFPM followed in our...

ea0022p760 | Thyroid | ECE2010

Follicular tumour in fine needle aspiration byopsy of thyroid: predictive factors of mallignancy

Vieira Alexandra , Carrilho Francisco , Ribeiro Cristina , Paiva Sandra , Martins Maria Joao , Fernandes Graca , Santos Jacinta , Martinho Mariana , Alves Marcia , Gouveia Sofia , Xavier da Cunha Fernanda , Carvalheiro Manuela

Introduction: About 20% of fine needle aspiration biopsy of thyroid (FNA) with result of follicular tumour (FT) is malignant. Several factors have been suggested as indicators of malignancy.Objectives: To determine predictive factors of malignancy in FNA with result of FT.Methods: We evaluated retrospectively 140 clinical files of patients with cytology (ultrasound-guided or palpation) of FT. Presence of relationship between malign...

ea0020p231 | Bone/Calcium | ECE2009

Bone and mineral metabolism before and after kidney–pancreas transplantation in patients with type 1 diabetes

Vaz Daniel , Martins L , Dias L , Henriques C , Oliveira F , Seca R , Lhamas A , Esteves S , Ribeiro A , Almeida R , Teixeira M , Dores J

Aims: End stage renal disease is associated with disorders of calcium and phosphate metabolism that favor the loss of bone mass.Kidney transplant may alter this unbalance restoring bone mass. Nevertheless, recent studies showed that 48 months after transplant, the loss of bone mass still is superior to general population. Post-transplant corticosteroid therapy is considered the main responsible for the loss of bone mass.The authors...

ea0014p451 | (1) | ECE2007

Familial hypocalciuric hypercalcemia: mutation in the calcium sensing receptor gene

Paiva Sandra , Ribeiro Cristina , Barros Luisa , Gomes Leonor , Melo Miguel , Guimarães Joana , Venâncio Margarida , Saraiva Jorge , Carvalheiro Manuela

Familial hypocalciuria hypercalcemia (FHH) is an autossomal dominant condition caused by mutations in the calcium sensing receptor gene. It is characterized by moderate hypercalcemia, with normal or slightly elevated PTH levels and hypocalciuria secondary to the increased calcium reabsorption at the distal tubule level.We present a case report of a 16 year old patient, who was referred to our department at the age of 14 because of obesity (BMI: 36.9 K/m<...

ea0014p605 | (1) | ECE2007

Familial acromegaly – the role of the AIP gene

Gueorguiev M , Lolli F , Chapple JP , Quinton R , Ribeiro-de-Oliveira A , Gadelha MR , Popovic V , Monson JP , Wass JAH , Frohman LA , Grossman AB , Korbonits M

Pituitary adenomas are present in ∼25% of autopsy samples, and recent studies have also suggested that clinically important pituitary adenomas are some 5 times more common than previously recognised. Acromegaly is almost always due to a sporadic growth-hormone secreting pituitary adenoma, but familial acromegaly has been reported occasionally. Linkage and loss of heterozygosity studies have shown that it is caused by a tumour suppressor gene located at 11q13; very recent...

ea0056gp10 | Acromegaly | ECE2018

Human growth hormone (GH) isoforms during oral glucose tolerance test in patients with acromegaly and in healthy subjects

Ulmer Esther , Schilbach Katharina , Haenelt Michael , Nicolay Shiva Sophia , Schwerdt Laura , Schweizer Junia Ribeiro de Oliveira Longo , Bartel Christopher , Schopohl Jochen , Strasburger Christian , Wu Zida , Bidlingmaier Martin

GH consists of various molecular isoforms. Most abundant is 22 kDa-GH (80–90% of total GH), followed by 20 kDa-GH (5–15% of total GH). The biological significance of 20 kDa-GH remains unclear, but its effects appear comparable to those of 22 kDa-GH. Acromegaly is characterized by chronic GH excess. Data on GH isoforms in acromegaly are scarce, but an increased 20 kDa-/22 kDa-GH-ratio (20k-ratio) has been described. Our aims were to compare the 20k-ratio in a larger c...